Losartan-induced azotemia in a diabetic recipient of a kidney transplant.
Cohen
L S
LS
Friedman
E A
EA
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001713:Biphenyl Compounds / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D004656:Enalapril / Q000009:adverse effects; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D016030:Kidney Transplantation; D019808:Losartan; D008297:Male; D008875:Middle Aged; D013777:Tetrazoles / Q000009:adverse effects*; D014511:Uremia / Q000139:chemically induced*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D004656:Enalapril; D019808:Losartan